X-Seal EU Post-Market Clinical Follow-Up Protocol

NCT02406612 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
47
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Essential Medical, Inc.